Eric Jutkowitz1,2, Courtney H Van Houtven3,4, Brenda L Plassman5,6, Vincent Mor1,2. 1. Department of Health Services, Policy & Practice, Brown University School of Public Health. 2. Providence Veterans Affairs (VA) Medical Center, Center of Innovation in Long Term Services and Supports, Providence, Rhode Island. 3. Durham ADAPT COIN, HSR&D, Durham VAMC. 4. Departments of Population Health Sciences. 5. Psychiatry and Behavioral Sciences. 6. Neurology, Duke University School of Medicine, Durham, NC.
Abstract
OBJECTIVE: To evaluate determinants of willingness to accept a treatment to return memory to normal among persons with cognitive impairment who received an amyloid positron emission tomography (PET) scan and their care partner and discordance in risk taking. METHODS: Using data from CARE-IDEAS (n=1872 dyads), a supplement of the Imaging Dementia-Evidence for Amyloid Scanning study, we predicted scan recipient's willingness to accept a risky treatment, the risk care partners believed their care recipient would accept, and discordance in these perceptions. RESULTS: Scan recipients were willing to accept a treatment with a 27.94% (SD=34.36) risk of death. Care partners believed their care recipient would accept a 29.68% (SD=33.74) risk of death; thus, overestimating risk acceptance by 1.74 (SD=41.88) percentage points. A positive amyloid PET scan was associated with willingness to accept greater risk. Poorer functioning of the care recipient was associated with care partners believing their care recipient would accept more risk. The amyloid PET scan result was not significantly associated with discordance, but poorer functioning of the care recipient resulted in care partners overestimating risk. CONCLUSIONS: Scan recipients were willing to accept a treatment with a high risk of death. Discordance was affected by scan recipient's having poorer functioning.
OBJECTIVE: To evaluate determinants of willingness to accept a treatment to return memory to normal among persons with cognitive impairment who received an amyloid positron emission tomography (PET) scan and their care partner and discordance in risk taking. METHODS: Using data from CARE-IDEAS (n=1872 dyads), a supplement of the Imaging Dementia-Evidence for Amyloid Scanning study, we predicted scan recipient's willingness to accept a risky treatment, the risk care partners believed their care recipient would accept, and discordance in these perceptions. RESULTS: Scan recipients were willing to accept a treatment with a 27.94% (SD=34.36) risk of death. Care partners believed their care recipient would accept a 29.68% (SD=33.74) risk of death; thus, overestimating risk acceptance by 1.74 (SD=41.88) percentage points. A positive amyloid PET scan was associated with willingness to accept greater risk. Poorer functioning of the care recipient was associated with care partners believing their care recipient would accept more risk. The amyloid PET scan result was not significantly associated with discordance, but poorer functioning of the care recipient resulted in care partners overestimating risk. CONCLUSIONS: Scan recipients were willing to accept a treatment with a high risk of death. Discordance was affected by scan recipient's having poorer functioning.
Authors: Arno de Wilde; Wiesje M van der Flier; Wiesje Pelkmans; Femke Bouwman; Jurre Verwer; Colin Groot; Marieke M van Buchem; Marissa Zwan; Rik Ossenkoppele; Maqsood Yaqub; Marleen Kunneman; Ellen M A Smets; Frederik Barkhof; Adriaan A Lammertsma; Andrew Stephens; Erik van Lier; Geert Jan Biessels; Bart N van Berckel; Philip Scheltens Journal: JAMA Neurol Date: 2018-09-01 Impact factor: 18.302
Authors: Eric Jutkowitz; Robert L Kane; Joseph E Gaugler; Richard F MacLehose; Bryan Dowd; Karen M Kuntz Journal: J Am Geriatr Soc Date: 2017-08-17 Impact factor: 5.562
Authors: F Reed Johnson; George Van Houtven; Semra Ozdemir; Steve Hass; Jeff White; Gordon Francis; David W Miller; J Theodore Phillips Journal: J Neurol Date: 2009-04-27 Impact factor: 4.849
Authors: F Reed Johnson; Semra Ozdemir; Carol Mansfield; Steven Hass; David W Miller; Corey A Siegel; Bruce E Sands Journal: Gastroenterology Date: 2007-05-03 Impact factor: 22.682
Authors: Hailey J James; Courtney Harold Van Houtven; Steven Lippmann; James R Burke; Megan Shepherd-Banigan; Emmanuelle Belanger; Terrie Fox Wetle; Brenda L Plassman Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Courtney H Van Houtven; Steven J Lippmann; Emmanuelle Bélanger; Valerie A Smith; Hailey J James; Megan Shepherd-Banigan; Eric Jutkowitz; Emily O'Brien; Jennifer L Wolff; James R Burke; Brenda L Plassman Journal: Med Care Date: 2020-09 Impact factor: 3.178